C4 Therapeutics, Inc.

CCCC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$55,499$126,590$29,754$76,124
Short-Term Investments$189,405$127,091$246,399$233,155
Receivables$3,102$11,799$1,473$5,716
Inventory$0$0-$60,962$0
Other Curr. Assets$9,761$5,709$70,893$10,694
Total Curr. Assets$257,767$271,189$287,557$325,689
Property Plant & Equip (Net)$63,378$71,088$77,516$35,053
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$22,359$28,008$60,962$142,200
Tax Assets$0$0$0$0
Other NC Assets$6,098$6,166$4,805$3,823
Total NC Assets$91,835$105,262$143,283$181,076
Other Assets$0$0$0$0
Total Assets$349,602$376,451$430,840$506,765
Liabilities
Payables$1,328$1,446$1,172$4,506
Short-Term Debt$5,774$5,219$6,987$1,334
Tax Payable$0$0$0$0
Deferred Revenue$18,712$15,471$16,618$31,800
Other Curr. Liab.$19,363$20,630$19,769$13,606
Total Curr. Liab.$45,177$42,766$44,546$51,246
LT Debt$59,982$65,757$80,165$41,545
Deferred Rev, NC$28,457$21,814$16,895$24,368
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$88,439$87,571$97,060$65,913
Other Liabilities$0$0$0$0
Cap. Leases$65,756$70,976$75,670$32,111
Total Liabilities$133,616$130,337$141,606$117,159
Equity
Pref Stock$0$0$0$0
Common Stock$7$6$5$5
Retained Earnings-$633,699-$528,383-$395,890-$267,715
AOCI$53-$127-$4,137-$775
Other Equity$849,625$774,618$689,256$658,091
Total Equity$215,986$246,114$289,234$389,606
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$349,602$376,451$430,840$506,765
Net Debt$10,257-$55,614$57,398-$33,245